Cardiovascular 2 Flashcards

1
Q

HF
Causes (3)

A

decreased pumping action
systemic fluid congestion
failure of vital organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Results of right side HF
(3)

A

pulmonary edema
coughing
peripheral edema (arms and legs mostly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Left side HF
(3)

A

affects all organ systems; decrease kidney function contributes to fluid retention
pulmonary edema
coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Heart Failure
Pathophysiology
*Increased workload →problems with

A

cardiac muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

*— ventricle typically fails first →can lead to — ventricle failure

A

Left
right

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Heart Failure
reduced –
decreased –
blood backed up in –
pulmonary –
increased workload on – ventricle
volume overload (3)
ventricles – to try to compensate
activation of – to compensate

A

cardiac output
perfusion
pulmonary vessels (SOB, foamy cough, pulmonary)
hypertension
R
venous congestion, peripheral edema, ascites
dilate
RAAS and neurohormonal responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Past Myocardial Infarction
>1 month
* Consider
(2)

A

severity of cardiac status and
comorbidities
appropriate management
protocols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Ejection Fraction can measure the
    degree of heart failure
    ➢Measures
A

amount (%) of blood that
leaves the left ventricle after
contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • Ejection Fraction (EF) %: 55% to 70%
A
  • Pumping Ability of the Heart: Normal
  • Level of Heart Failure/Effect on Pumping: Heart function may be normal or you may have heart failure with preserved EF (HF-pEF).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • Ejection Fraction (EF) %: 40% to 54%
A
  • Pumping Ability of the Heart: Slightly below normal
  • Level of Heart Failure/Effect on Pumping: Less blood is available so less blood is ejected from the ventricles. There is a lower-than-normal amount of oxygen-rich blood available to the rest of the body. You may not have symptoms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • Ejection Fraction (EF) %: 35% to 39%
A
  • Pumping Ability of the Heart: Moderately below normal
  • Level of Heart Failure/Effect on Pumping: Mild heart failure with reduced EF (HF-rEF).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Ejection Fraction (EF) %: Less than 35%
A
  • Pumping Ability of the Heart: Severely below normal
  • Level of Heart Failure/Effect on Pumping: Moderate-to-severe HF-rEF. Severe HF-rEF increases the risk of life-threatening heartbeats and cardiac dyssynchrony/desynchronization (right and left ventricles do not pump in unison).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EF =

A

blood vol. pumped out x 100
blood vol. in chamber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

normal EF

A

50-70% is pumped out
during each contraction (usually comfortable during activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

borderline EF

A

41-49% is pumped out
during each contraction (symptoms may become noticeable during activty)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

reduced EF

A

< 40% is pumped out
during each contraction (symptoms may become noticeable even during rest)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

*Systolic failure

A

➢ Reduced left ventricular ejection fraction (HFrEF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

*Diastolic failure

A

➢ Normal left ventricular ejection fraction (HFpEF)??

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

*Cardiac abnormalities
(3)

A

➢ Valvular Disease
➢ Arrhythmias
➢ Myocardial necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

*Decompensation
(3)

A

➢ Inability to compensate
➢ Increased peripheral blood flow
➢ Increased metabolic needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Predisposing Factors
➢ Acute CVD
(1)
➢ Chronic CVD
(3)

A

oMI

oHypertension
oCoronary artery disease
oArrhythmia, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HF
Result (signs and symptoms)
(2)

A

➢ Volume overload
➢ Inadequate perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HF
Complications
(3)

A

➢ Cardiac arrest (stops beating)
➢ Myocardial infarction (blood flow blocked)
➢ Stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Heart Failure
Signs

A

➢Rapid, shallow breathing
➢Inspiratory rales (crackles)
➢Increased heart rate
➢Distended jugular (neck) veins
➢Peripheral edema
➢Ascites
➢Cyanosis
➢Weight gain
➢Clubbing of fingers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Heart Failure
Symptoms
(6)

A

➢Fatigue and weakness
➢Orthopnea - shortness of breath (dyspnea) in recumbent position
➢Exercise intolerance
➢Muscular fatigue
➢Weight gain
➢GI distress
(nausea, vomiting & constipation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Heart Failure Medical Management
* Pharmacologic and non-pharmacologic (see previous slide info)
STAGE A
STAGE B
STAGE C
STAGE D
* Patients with severe heart failure may require –
* Intermediate therapy is the –

A

ACE inhibitor
ACE inhibitor, beta blocker
ACE inhibitor, beta blocker, diuretic for fluid retention
ACE inhibitor, beta blocker, diuretic for fluid retention, decision ab appropriate level of care

cardiac transplantation
Left Ventricular Assist Device (LVAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Effect of dental treatment
before cardiac valve surgery:
Systematic review and meta-analysis
Looked at effect dental treatment (clearance)
prior to cardiac valve surgery or LVAD
implantation
Outcomes:
Morbidity (IE, post-surgical infection, length of
hospital stay) and mortality (all cause)
Results
(3)

A
  • LVAD studies did not meet inclusion criteria
  • Low certainty evidence for valvular surgery
  • Data cannot support or refute efficacy of dental
    treatment (clearance) prior to cardiac surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

In most cases of HF, the dentist will need to obtain a medical
consultation with the patient’s cardiologist to determine
(5)

A
  • The patient’s physical status
  • Laboratory test results
  • Level of control
  • Compliance with medications and recommendations
  • Overall stability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

A major issue for patients with symptomatic HF
(5)

A
  • Symptoms could abruptly worsen
  • Acute failure
  • Fatal arrhythmia
  • Stroke
  • MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

HF
class 1

A

physical limitation: no limitation
no dyspnea, fatigue or palpitations with physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

HF
class 2

A

physical activity: slight limitation
fatigue, dyspnea, palpations present w physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

HF
class 3

A

physical activity: marked limitation
less than normal physical activity results in symptoms, comfy at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

HF
class 4

A

physical activity: severely limited, exacerbates symptoms
symptoms present at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Class I:

A

routine dental care ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Class II:

A

medical consultation required, routine dental care likely ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Class III and IV:

A

consider referral to specialized care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Low Level Intervention
(6)

A
  • Health/medical evaluation
  • Exams
  • Prophy
  • Radiographs
  • Optical oral scans
  • Alginate impressions
38
Q

Moderate Intervention
(4)

A

*SRP (scaling and root planning)
*Simple restorative procedures; 1-2 teeth
*Simple extractions; 1-2 teeth
*Restorative impressions needing retractions
and longer setting times

39
Q

High Risk Intervention
(5)

A

*Complex restorative procedures on >2 teeth
*Multiple extractions
*Surgical extractions
*Implant placement
*Full arch impressions
*Dental care under general anesthesia

40
Q

Heart Failure
Additional HF Dental Management Considerations
(3)

A
  • Short, “stress-free” appointments
  • Chair position
  • If patient taking digitalis glycoside (digoxin) –positive inotrope
41
Q
  • Chair position
A

➢Patients with HF may not tolerate supine position (pulmonary edema)

42
Q
  • If patient taking digitalis glycoside (digoxin) –positive inotrope
    (2)
A

➢Epinephrine should be avoided, if possible
➢Combination increases the risk for arrhythmia

43
Q

There are no — manifestations related to HF

A

oral

44
Q

Many of the drugs used to manage HF can cause

A

dry mouth
altered taste and oral ulcerative lesions (discussed previously)

45
Q

Valvular Disease
* Compromised function of the
* Valves direct blood flow into

A

heart valves
different heart chambers

46
Q

➢ Atrioventricular:
➢ Semilunar

A

oTricuspid and Mitral

oAortic and Pulmonary

47
Q

Valvular Disease
* Valves open and close
~

A

85,000/QD @ 60/min
100,800/QD @ 70/min

48
Q
  • Valvular Stenosis
A

➢ Do not open properly

49
Q
  • Valvular Insufficiency
    (2)
A

➢ Do not close properly
➢ Associated with regurgitation

50
Q

Fibrosis

A

➢ Stiff, sclerosis, stenosis causing either stenosis or insufficency

51
Q

Myxomatous degeneration
(2)

A

➢ Benign loose CT tumorous changes where valves become Floppy, prolapse, regurgitation
➢ Causes insufficiency

52
Q

Valvular Heart Disease
Risk Factors (other)
(3)

A
  • Calcifications
  • Congenital defects (bicuspid aortic valve, mitral valve prolapse)
  • Infections
53
Q

Valvular Heart Disease
Signs
(4)

A

➢ Murmurs
➢ Syncope
➢ Heart failure
➢ Shortness of breath

54
Q

Valvular Heart Disease
Symptoms
(3)

A

➢ Heart failure
➢ Exercise intolerance
➢ Shortness of breath (can also be a sign)

55
Q

Valvular Heart Disease
Medical Management
(2)

A
  • Treatment is primarily surgical
  • Valve replacement (more common)
56
Q

Valve replacement (more common)
➢Mechanical Implants
(2)

A

oSilicone
oRequires long-term anticoagulation

57
Q

Valve replacement (more common)
➢Bioprosthetic Implants
(3)

A

oAllograft , bovine graft, etc.; decellularized CT
with a less antigenic structural matrix
oshort-term anticoagulation
oLong-term antiplatelet therapy)

58
Q

Predisposition for

A

infective endocarditis

59
Q

Questions for Patient with Valvular Heart Disease
* Screening

A

➢ Shortness of breath, chest pain, etc.

60
Q

Questions for Patient with Valvular Heart Disease
* Valve replacement

A

➢ Have you ever had valve replacement surgery ?
oWhat type? When?
oWhat kind of valve do you have (mechanical or bioprosthetic)

61
Q

Questions for Patient with Valvular Heart Disease
* Anticoagulation/Bleeding

A

➢ Do you take a blood thinner?
oHow often do you have your INR measured?
oWhat was your last reading? What has been your range?
oWhen is your next reading?
➢ Do you take aspirin or clopidogrel?
➢ Does it take a long for you to stop bleeding after a cut?
➢ Have you ever been hospitalized due to bleeding?

62
Q

Questions for Patient with Valvular Heart Disease
* Previous Infective Endocarditis

A

➢ Have you ever had infective endocarditis?
oWhen?
oAre you allergic to any antibiotics?
oIf, so what type of reaction occurs?

63
Q

Questions for Patient with Valvular Heart Disease
Oral manifestations

A
  • No specific oral manifestations of Valvular Heart Disease
64
Q

Questions for Patient with Valvular Heart Disease
* Bleeding

A

➢ Complications from anticoagulation or
➢ Complications from antiplatelet therapy

65
Q

Questions for Patient with Valvular Heart Disease
* Infections

A

➢Risk of developing infective endocarditis
➢Requires antibiotic prophylaxis when valves have been replaced

66
Q

Questions for Patient with Valvular Heart Disease
* Drug Effects

A

➢ Potential drug interactions from CVD pharmacologic management (as
previously discussed), especially when comorbidities are present

67
Q

Dental Considerations
(4)

A
  • Assess ability to tolerate care in context of underlying condition and
    comorbidities
  • Assess Bleeding Risk
  • Infections
  • Drug Effects
68
Q
  • Assess Bleeding Risk
    (2)
A

➢ Obtain INR the day of the invasive procedures
➢ Have local hemostatic measures in place

69
Q
  • Infections
    (1)
A

➢Determine need for antibiotic prophylaxis and antibiotic of choice

70
Q
  • Drug Effects
A

➢ Review medication list
oDrug adverse effects
oDrug-drug interactions

71
Q

Infective Endocarditis

A

infection of inner layer of heart- usually affects cardiac valves

72
Q

Infective Endocarditis
was almost always fatal until development of

A

penicillin
15000 cases diagnosed in US each year

73
Q

endocarditis
precipitated by —; potential death from —

A

bacteria/fungal infection
emboli and valvular disturbance

74
Q

Infective Endocarditis
etiology and pathophysiology
key-

A

blood turbulence within heart allows causative agent to infect previously damaged valves or other endothelial surfaces

75
Q

AHA Cardiovascular Indications for Antibiotic Prophylaxis
(4)

A
  • Prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts
  • Prosthetic material used for cardiac valve repair, such as annuloplasty rings and chords
  • Previous endocarditis
  • Cardiac transplantation recipients with valve regurgitation due to a structurally abnormal
    valve
76
Q

Congenital heart disease (CHD) only in the following categories:
(3)

A

➢Unrepaired cyanotic CHD, including those with palliative shunts and conduits
➢Completely repaired congenital heart defect with prosthetic material or device, whether
placed by surgery or catheter intervention, during the first six months after the procedure
➢Repaired CHD with residual shunts or valvular regurgitation at the site or adjacent to the
site of a prosthetic patch or prosthetic device (which inhibit endothelialization)

77
Q

Infective Endocarditis
high risk
(5)

A

mechanical prosthetic heart valve
natural prosthetic heart valve
prior IE
valve repair with prosthetic material
most congenital heart diseases

78
Q

Infective Endocarditis
moderate risk
(4)

A

valve repair without prosthetic material
hypertrophic cardiomyopathy
mitral valve prolapse with regurgitation
acquired valvular dysfunction

79
Q

Infective Endocarditis
low risk
(4)

A

innocent heart murmurs
mitral valve prolapse without regurgitation
coronary artery disease
people with pacemakers / defibrilators

80
Q

prophylactic ab are generally recommend only for people in the

A

high risk category

81
Q

Antibiotic prophylaxis is recommended for
ONLY AT RISK PATIENTS who have
procedures that:
(3)

A
  1. Manipulate the gingival tissue
    2.Manipulate the periapex of teeth
    3.Perforate the oral mucosa
82
Q

OBS.:If the dosage of antibiotic is
inadvertently not administered before the
procedure, the dosage may be administered

A

up
to 2 hours after the procedure.

83
Q

Patients already taking antibiotics
If a patient is taking a beta-lactam (penicillin, amoxicillin, etc.) for an
active, existing infection resistant strains have likely been selected

A
  • If urgent/emergency dental treatment is necessary
    ➢ Prescribe azithromycin or clarithromycin
84
Q
  • If dental treatment is elective
A

➢ Wait 10 days after completion of the antibiotic for their
active infection, then prescribe amoxicillin according to
AHA guidelines

85
Q

Conditions that DO NOT require Antibiotic Prophylaxis
(5)

A
  • Heart murmur
  • Mitral valve prolapse
  • Mitral valve prolapse with regurgitation
  • Rheumatic fever
  • Stent or coronary artery bypass graft (cabg)
86
Q

Note: If a heart murmur is due to specific cardiac condition (e.g., previous
endocarditis, prosthetic heart valve, complex congenital cyanotic heart
disease), AHA continues to recommend

A

antibiotic prophylaxis for most
dental procedures

87
Q

Procedures that DO NOT require Antibiotic Prophylaxis
(4)

A
  • Radiographs
  • Placement of appliances
  • Routine local injections
  • Tooth shedding or trauma
88
Q

These procedures are unlikely to:
(3)

A
  1. Manipulate the gingival tissue
    2.Manipulate the periapex of teeth
    3.Perforate the oral mucosa
89
Q

*— of bacteremia or bacteria — is a predictor of IE chances

A

Size, number

90
Q

*Infective endocarditis (IE) is not always caused by

A

bacterial infection

91
Q

*Continuing evidence questions the validity of

A

antibiotic prophylaxis practice to
prevent IE

92
Q

*Daily exposure to — during everyday activities (toothbrushing, chewing)
likely cause most cases of IE; not —

A

bacteremias
dentistry

*Encourage good oral hygiene practices